Michael Serenko
Overview
Explore the profile of Michael Serenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faber C, Attal N, Lauria G, Dworkin R, Freeman R, Dawson K, et al.
EClinicalMedicine
. 2023 May;
59:101971.
PMID: 37152360
Background: No pharmacological treatments are specifically indicated for painful small fibre neuropathy (SFN). CONVEY, a phase 2 enriched-enrolment study, evaluated the efficacy and safety of vixotrigine, a voltage- and use-dependent...
2.
Zhao Y, Kotecha M, Finnigan H, Serenko M, Naik H
Clin Drug Investig
. 2022 Aug;
42(10):829-837.
PMID: 36045316
Background And Objective: Vixotrigine is a voltage-dependent and use-dependent sodium channel blocker in development for the treatment of neuropathic pain. Metabolism of vixotrigine is primarily through glucuronidation, resulting in the...
3.
Raghu G, Mouded M, Chambers D, Martinez F, Richeldi L, Lancaster L, et al.
Am J Respir Crit Care Med
. 2022 Jun;
206(9):1128-1139.
PMID: 35771569
Treatment options for idiopathic pulmonary fibrosis (IPF) are limited. To evaluate the efficacy and safety of BG00011, an anti-αβ IgG1 monoclonal antibody, in the treatment of patients with IPF. In...
4.
Block G, Chertow G, Sullivan J, Deng H, Mather O, Tomlin H, et al.
PLoS One
. 2019 Mar;
14(3):e0213774.
PMID: 30875390
Background: Calcimimetics have been shown to be effective and safe therapies for the treatment of secondary hyperparathyroidism (sHPT), a serious complication of disordered mineral metabolism associated with dialysis-dependent chronic kidney...
5.
Kroenke M, Weeraratne D, Deng H, Sloey B, Subramanian R, Wu B, et al.
J Immunol Methods
. 2017 Mar;
445:37-44.
PMID: 28274835
The immunogenicity risk assessment and bioanalytical strategy for novel therapeutics should account for both unique biophysical properties and potential consequences of immunogenicity. When assessing the immunogenicity risk of etelcalcetide, a...
6.
Wang Y, Nomikos G, Karim A, Munsaka M, Serenko M, Liosatos M, et al.
Clin Pharmacol Drug Dev
. 2016 Apr;
2(4):298-309.
PMID: 27121934
This double-blind, randomized, placebo- and positive-controlled, parallel-group study evaluated the effect of vortioxetine (Lu AA21004), an investigational multimodal antidepressant, on QT interval in accordance with current guidelines of the International...
7.
Mahableshwarkar A, Jacobsen P, Serenko M, Chen Y, Trivedi M
J Clin Psychiatry
. 2015 Jun;
76(5):583-91.
PMID: 26035186
Background: This 8-week, randomized, double-blind, placebo-controlled study, conducted August 2010-May 2012 in the United States, evaluated the safety and efficacy of vortioxetine 10 mg and 15 mg in patients with...
8.
Jacobsen P, Mahableshwarkar A, Serenko M, Chan S, Trivedi M
J Clin Psychiatry
. 2015 Jun;
76(5):575-82.
PMID: 26035185
Context: Vortioxetine (Lu AA21004) is an antidepressant with a mechanism of action thought to be related to a combination of 2 pharmacologic actions: direct modulation of several receptors and inhibition...
9.
Chen G, Zhang W, Serenko M
J Clin Pharmacol
. 2015 Feb;
55(6):671-9.
PMID: 25641606
Vortioxetine is an antidepressant with multimodal activity approved for the treatment of major depressive disorder. Two separate randomized, placebo-controlled trials evaluated the effects of multiple doses of vortioxetine (10 mg/day)...
10.
Mahableshwarkar A, Jacobsen P, Chen Y, Serenko M, Trivedi M
Psychopharmacology (Berl)
. 2015 Jan;
232(12):2061-70.
PMID: 25575488
Rationale: Vortioxetine has reduced depressive symptoms in adults with major depressive disorder (MDD) in multiple clinical trials. Objectives: The aim of this study is to evaluate the efficacy, safety, and...